PDUFA Negotiations Begin With FDA Seeking Review System Reform
This article was originally published in The Pink Sheet Daily
Executive Summary
Fee structure changes and process enhancements floated during opening session between industry and agency.
You may also be interested in...
FDA Safety Reports: Firms Want Advance Notice Before Public Release
PDUFA renewal could establish process that allows firms early warnings about Sentinel and other safety data announcements.
FDA's Ongoing User Fee System Upgrade Limits Payment Options
But it comes at a time when there is traditionally a lull in filings of generic drug applications.
PDUFA VI: FDA Wary Of Industry Proposals With More Metrics
Review system proposals could overburden staff, FDA says; formal meeting goals already on tap for changes.